Comments on National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version)

Jiahui Chen^{1

2}, Zhaode Bu³, Jiafu Ji³

Affiliations

¹ Department of Gastric Surgery, the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou 310022, China.
² Key Laboratory of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer of Zhejiang Province, Hangzhou 310022, China.
³ Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China.

Jiahui Chen et al. Chin J Cancer Res. 2022.

. 2022 Oct 30;34(5):453-455.

doi: 10.21147/j.issn.1000-9604.2022.05.04.

Jiahui Chen^{1

2}, Zhaode Bu³, Jiafu Ji³

¹ Department of Gastric Surgery, the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou 310022, China.
² Key Laboratory of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer of Zhejiang Province, Hangzhou 310022, China.
³ Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China.

No abstract available

References

1. Sun D, Cao M, Li H, et al Cancer burden and trends in China: A review and comparison with Japan and South Korea. Chin J Cancer Res. 2020;32:129–39. doi: 10.21147/j.issn.1000-9604.2020.02.01. - DOI - PMC - PubMed
1. Yang L, Ying X, Liu S, et al Gastric cancer: Epidemiology, risk factors and prevention strategies. Chin J Cancer Res. 2020;32:695–704. doi: 10.21147/j.issn.1000-9604.2020.06.03. - DOI - PMC - PubMed
1. National Health Commission Of The People’s Republic Of China National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version) Chin J Cancer Res. 2022;34:207–37. doi: 10.21147/j.issn.1000-9604.2022.03.04. - DOI - PMC - PubMed
1. National Health Commission Of The People’s Republic Of China Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version) Chin J Cancer Res. 2019;31:707–37. doi: 10.21147/j.issn.1000-9604.2019.05.01. - DOI - PMC - PubMed
1. Janjigian YY, Shitara K, Moehler M, et al First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398:27–40. doi: 10.1016/S0140-6736(21)00797-2. - DOI - PMC - PubMed